Literature DB >> 27964927

Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.

Xue Li1, Li Zeng2, Chuanwu Cao3, Chenhui Lu4, Weishuai Lian5, Jianhong Han6, Xiaojun Zhang7, Jing Zhang8, Tao Tang9, Maoquan Li10.   

Abstract

Diabetic nephropathy is a common kidney condition in patients with diabetes mellitus, which can result in renal failure. Pyroptosis, the process of pro-inflammatory programmed cell death, plays an important role in the pathogenesis of this disease. Long non-coding RNA MALAT1 has also been shown to be involved in diabetic nephropathy. Here, we investigated the role of MALAT1 and the microRNA miR-23c and its target gene ELAVL1 in renal tubular epithelial cells. Our data demonstrated that MALAT1 expression was substantially increased but miR-23c was decreased in streptozotocin-induced diabetic rats and in high-glucose-treated HK-2 cells. Downregulation of MALAT1 or upregulation the expression of miR-23c inhibited pyroptosis in HK-2 cells. In an effort to understand the signaling mechanisms underlying the pro-pyroptotic properties of MALAT1 and the anti-pyroptotic properties of miR-23c, we found that inhibiting the expression of MALAT1 downregulated the expression of ELAVL1, NLRP3, Caspase-1 and the pro-inflammatory cytokine IL-1β. These findings were replicated by upregulation of miR-23c. Moreover, luciferase assays showed that miR-23c, as a target of MALAT1, directly repressed ELAVL1 expression and then decreased the expression of its downstream protein NLRP3. The expression of MALAT1 antagonized the effect of miR-23c on the downregulation of its target ELAVL1 and inhibited hyperglycemia-induced cell pyroptosis. This mechanism may contribute to a better understanding of diabetic nephropathy pathogenesis and facilitate the development of new therapeutic strategies for the treatment of this disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetic nephropathy; Long non-coding RNA; MALAT1; MiR-23c; Pyroptosis

Mesh:

Substances:

Year:  2016        PMID: 27964927     DOI: 10.1016/j.yexcr.2016.12.006

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  80 in total

Review 1.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 2.  The Possibility and Molecular Mechanisms of Cell Pyroptosis After Cerebral Ischemia.

Authors:  Zhaofei Dong; Kuang Pan; Jingrui Pan; Qingxia Peng; Yidong Wang
Journal:  Neurosci Bull       Date:  2018-10-10       Impact factor: 5.203

Review 3.  Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.

Authors:  Sumit Kar; Tyler N Kambis; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

Review 4.  Epigenetic Risk Profile of Diabetic Kidney Disease in High-Risk Populations.

Authors:  Lixia Xu; Rama Natarajan; Zhen Chen
Journal:  Curr Diab Rep       Date:  2019-02-07       Impact factor: 4.810

Review 5.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

6.  Deciphering the role of circulating lncRNAs: RNCR2, NEAT2, CDKN2B-AS1, and PVT1 and the possible prediction of anti-VEGF treatment outcomes in diabetic retinopathy patients.

Authors:  Eman A Toraih; Ahmed A Abdelghany; Noha M Abd El Fadeal; Essam Al Ageeli; Manal S Fawzy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-20       Impact factor: 3.117

7.  Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.

Authors:  Syamantak Majumder; Mitchell J Hadden; Karina Thieme; Sri N Batchu; Divya Niveditha; Shibasish Chowdhury; Veera Ganesh Yerra; Suzanne L Advani; Bridgit B Bowskill; Youan Liu; Hana Vakili; Tamadher A Alghamdi; Kathryn E White; Laurette Geldenhuys; Ferhan S Siddiqi; Andrew Advani
Journal:  Diabetologia       Date:  2019-08-09       Impact factor: 10.122

8.  HBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma.

Authors:  Zhouhua Hou; Xuwen Xu; Xiaoyu Fu; Shuhui Tao; Jiebin Zhou; Shuiping Liu; Deming Tan
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

Review 9.  Long Noncoding RNAs and Their Therapeutic Promise in Diabetic Nephropathy.

Authors:  Juan D Coellar; Jianyin Long; Farhad R Danesh
Journal:  Nephron       Date:  2021-04-14       Impact factor: 2.847

10.  Regulated cell death in cisplatin-induced AKI: relevance of myo-inositol metabolism.

Authors:  Fei Deng; Xiaoping Zheng; Isha Sharma; Yingbo Dai; Yinhuai Wang; Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.